Summit Therapeutics (SMMT) Market Cap 2015–2026

As of November 13, 2026, Summit Therapeutics had a market cap of $11.32 billion, which decreased by 6.14% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.

Data updated: Nov 13, 2026, 4:00 PM ET
Summit Therapeutics logo

Summit Therapeutics, Inc. (SMMT)

🌍 United States 📈 NASDAQ 🏭 Health Care 🏢 Biotechnology
Latest Market Cap
$11.32B ▼ 6.14%
Start of 2026
$13.02B ▼ 13.06%
1 Year Ago
$13.593B ▼ 16.72%
All-Time High
$27.256B ▼ 58.47%


Loading data...

Note: Each point on the chart represents the market capitalization at the end of the trading day.
Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.

📈 Summit Therapeutics Market Cap History by Year and Month

Summit Therapeutics Market Cap History by Year and Month
Year / MonthMarket Cap% Change
2026$11.32B▼ 13.06%
$11.32B▼ 10.94%
$12.71B▼ 5.22%
$13.41B▲ 24.17%
$10.8B▲ 4.55%
$10.33B▼ 8.66%
$11.31B▼ 16.90%
$13.61B▼ 18.21%
$16.64B▲ 13.20%
$14.7B▲ 19.03%
$12.35B▲ 14.56%
$10.78B▼ 17.20%
2025$13.02B▼ 1.09%
2024$13.163B▲ 619.61%
2023$1.829B▲ 113.79%
2022$0.856B▲ 224.43%
All market cap values reflect closing prices for the period shown.

📊 Summit Therapeutics Market Cap and Other Industry Peers

Below are selected companies for comparison based on industry, sub-industry, and sector:

  1. $16.96B
  2. $16.88B
  3. $15.35B
  4. $11.42B
  5. $11.32B
  6. $11.08B
  7. $10.88B
  8. $9.93B
  9. $9.46B
  10. $9.17B
  11. $9.04B
  12. $8.54B
  13. $7.97B
  14. $7.81B
  15. $6.74B
  16. $6.61B
  17. $5.3B
  18. $5.19B
  19. $4.97B
  20. $4.84B

Data reflect the most recent market capitalization values available.

Note: Market capitalization figures are based on available sources and may differ slightly from actual values, particularly for historical data.